https://www.selleckchem.com/products/v-9302.html
We evaluate tranexamic acid use in high-risk shoulder arthroplasty patients, hypothesizing that tranexamic acid will decrease transfusion rates in patients with low preoperative haematocrit. A retrospective review of shoulder arthroplasty patients with preoperative anaemia compared those treated with and without perioperative tranexamic acid. Inclusion criterion was any shoulder arthroplasty with a preoperative haematocrit (Hct) 38%. Tranexamic acid was given generally as 1 g intravenously before incision and 1 g during wound closure
Like
Comment
Share
